The infant nutrition market has shifted one notch upwards, adjusting to safety concerns and stricter requirements. Shane Starling speaks to DSM’s Fabiana Assis on how the firm has raised the bar in response.
“A year of stark contrasts” as DSM board chairman, Feike Sijbesma called it, has seen DSM turn a near €1bn profit but left the Dutch ingredients giant unable to make a forecast for this year as the economic crisis sets in.
The European Food Safety Authority (EFSA) has deemed lutein safe for use in infant formula in doses up to 250-300mg/l and 500mg/l in follow-on formula.